Wellcome Sanger Institute
Hanna Najgebauer is a postdoctoral fellow specializing in functional genomics and single cell biology at the Wellcome Sanger Institute since November 2020. Prior to this role, Najgebauer served as a postdoctoral fellow in cancer genomics at the European Bioinformatics Institute | EMBL-EBI from April 2017 to November 2020 and held a position as a MRC postdoctoral fellow in cardiovascular genomics at Imperial College London from February 2016 to March 2017. Najgebauer completed a PhD in cellular and molecular physiology at the University of Liverpool after undertaking a Cancer Research UK PhD Studentship there from October 2011 to December 2015. Previous research experience includes positions at the University of Glasgow, the University of Southern Denmark, and the Medical University of Silesia, where Najgebauer received a Master of Science in biotechnology.
This person is not in any offices
Wellcome Sanger Institute
1 followers
The Wellcome Sanger Institute is a world leader in genomics research. We generate and analyse data at a scale not easily possible elsewhere. We apply and explore genomic technologies to advance the understanding of biology and improve health. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth.